Filing Details
- Accession Number:
- 0000912282-23-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 13:52:53
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-15 13:52:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385818 | Aytu Biopharma Inc | AYTU | Pharmaceutical Preparations (2834) | 470883144 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566240 | R. Joshua Disbrow | C/O Aytu Biopharma, Inc. 373 Inverness Parkway, Suite 206 Englewood CO 80112 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-06-14 | 14,000 | $1.86 | 71,591 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported in Column 4 above is an average weighted price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023.
Billionaire Hedge Funds
